
    
      A Randomized Double-Blind, Double Dummy, Placebo-Controlled, Parallel-Group, Multicenter Dose
      Ranging Study to Evaluate the Efficacy and Safety of GW685698X Inhalation Powder Once Daily
      and Fluticasone Propionate Inhalation Powder Twice Daily compared with Placebo for 8 Weeks in
      Adolescent and Adult Subjects with Persistent Asthma Symptomatic on Moderate-Dose ICS Therapy
    
  